The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry-Reference-Cited by-同舟云学术

The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry

Published:2022-12-27 Issue:1 Volume:17 Page:85-98
ISSN:1747-4124
Container-title:Expert Review of Gastroenterology & Hepatology
language:en
Short-container-title:Expert Review of Gastroenterology & Hepatology

Author:

Dalavaye Nishaanth¹,Erridge Simon¹²,Nicholas Martha¹,Pillai Manaswini¹,Bapir Lara¹,Holvey Carl²,Coomber Ross²³,Rucker James J²⁴⁵,Hoare Jonathan¹²,Sodergren Mikael H¹²^ORCID

Affiliation:

1. Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK

2. Sapphire Medical Clinics, London, UK

3. St. George’s Hospital NHS Trust, London, UK

4. Department of Psychological Medicine, Kings College London, London, UK

5. South London & Maudsley NHS Foundation Trust, London, UK

Funder

funding

Publisher

Informa UK Limited

Subject

Gastroenterology,Hepatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474124.2022.2161046

Reference91 articles.

1. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

2. Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?

3. Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA) patient survey

4. Employment status, difficulties at work and quality of life in inflammatory bowel disease patients

5. Economic burden of inflammatory bowel disease: a UK perspective

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of global monitoring systems for the side effects and adverse events associated with medicinal cannabis use: a scoping review using a systematic approach;BMJ Open;2024-07

2. Pharmaceutical Potential of Remedial Plants and Helminths for Treating Inflammatory Bowel Disease;Pharmaceuticals;2024-06-21

3. Emerging Natural Therapies for the Treatment of Inflammatory Bowel Disease;Current Pharmaceutical Biotechnology;2024-04-22

4. An overview of global monitoring systems for the side effects and adverse events associated with medicinal cannabis use: A scoping review using a systematic approach;2024-02-04

5. UK Medical Cannabis Registry: a case series analyzing clinical outcomes of medical cannabis therapy for generalized anxiety disorder patients;International Clinical Psychopharmacology;2024-02-02